EP
BDSI

Eversept Partners’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Eversept Partners’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-583,504
Closed -$2.54M – 78
2020
Q2 		$2.54M Buy
583,504
+460,802
+376% +$2.07M 0.35% 42
2020
Q1 		$465K Sell
122,702
-212,783
-63% -$1.05M 0.12% 57
2019
Q4 		$2.12M Sell
335,485
-372,535
-53% -$2.19M 0.37% 46
2019
Q3 		$2.98M Buy
708,020
+351,746
+99% +$1.5M 0.92% 26
2019
Q2 		$1.66M Buy
+356,274
New +$1.66M 0.46% 39

Other funds holding BDSI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Eversept Partners's BDSI Position: Q3 2020 in Review

Eversept Partners sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2020, closing a stake of 583,504 shares — an estimated $2.54M sold.

Eversept Partners first reported a position in BDSI in Q2 2019 and held it in 5 quarters. The position peaked at $2.98M in Q3 2019. 147 funds tracked by Wall St. Rank hold BDSI as of Q3 2020.

  • Eversept Partners reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2020 after selling out during the quarter.
  • Eversept Partners sold 583,504 BioDelivery Sciences International, Inc. shares in Q3 2020, an estimated $2.54M.
  • Eversept Partners first reported a position in BioDelivery Sciences International, Inc. in Q2 2019 and held it in 5 quarters.
  • Eversept Partners's BioDelivery Sciences International, Inc. position peaked at $2.98M in Q3 2019.
  • 147 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2020.

Based on Eversept Partners's 13F filing for Q3 2020, filed 12 Nov 2020.